10 December 2019
Rory Kelsey, Spire Nottingham Imaging Manager with Andreas and Peter from Nocimed. MRI scanner featured with advanced Nocimed technology.
Nocimed, a leader in the diagnosis of Degenerative Disc Disease (DDD) pain using a non-invasive test measuring the biomarkers associated with disc pain, has launched in Europe at Spire Nottingham Hospital.
Nocimed has been marketing its unique technology to healthcare clinicians focusing on spine surgery, radiology and pain management using images from existing MRI equipment to perform the scan. NociScan detects the presence of chemical biomarkers associated with disc pain and structural integrity of the annulus of the disc making diagnosis faster and less uncomfortable for the patient.
“The opportunity to be the first site in the UK for NociScan allows Spire Nottingham Hospital to expand its spinal diagnostic capabilities, and offer innovative services for the benefit of our Consultants and Patients”, said Ed Ireland, Director of Clinical Services at Spire Nottingham Hospital. “We welcome this new innovation.”
Any patients requiring more information on accessing this scan at Spire Nottingham can call our Private Treatment Advisors on 0115 937 7735 or email firstname.lastname@example.org.